Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
203 results about "Atrial cavity" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
The atrial cavities in Pyrosoma are clearly lined by epiblast, just as in simple Ascidians. The Works of Francis Maitland Balfour, Volume III (of 4) Francis Maitland Balfour. When the young colony is ready to become free, it escapes from the atrial cavity of the parent, and increases in size by budding.
Ultrasound pulmonary vein isolation
A catheter introduction apparatus provides an ultrasound assembly for emission of ultrasound energy. In one application the catheter and the ultrasound assembly are introduced percutaneously, and transseptally advanced to the ostium of a pulmonary vein. An anchoring balloon is expanded to center an acoustic lens in the lumen of the pulmonary vein, such that energy is converged circumferentially onto the wall of the pulmonary vein when a transducer is energized. A circumferential ablation lesion is produced in the myocardial sleeve of the pulmonary vein, which effectively blocks electrical propagation between the pulmonary vein and the left atrium.
Owner:BIOSENSE
Methods and devices for occlusion of an atrial appendage
Some embodiments of the invention provide a system for occluding a left atrial appendage of a patient. Some embodiments of the system can include a ring occluder that can be positioned around the left atrial appendage and a ring applicator to position the ring occluder with respect to the left atrial appendage. One embodiment discloses a method of accessing endocardial surfaces of the heart through the atrial appendage. Additional embodiments of the invention provide a clip occluder that can be positioned around the left atrial appendage. A clip applicator can position the clip occluder with respect to the left atrial appendage.
Owner:MEDTRONIC INC
Method and devices for treating atrial fibrillation by mass ablation
InactiveUS20060009756A1Reduce the total massUltrasound therapyInfusion devicesAtrial cavityChest cavity
Apparatus and method for ablating target tissue including a non-linear area of tissue in the left atrium of a patient. The method can include selecting an ablation apparatus having an ablator with a tissue engagement section, penetrating a chest cavity of the patient, and identifying the target tissue. The method can also include positioning the ablation apparatus adjacent to the target tissue so that the tissue engagement section can transfer ablation energy to the target tissue. The method can further include energizing the tissue engagement section with ablation energy in order to create a footprint on the non-linear area of tissue in the left atrium and to reduce an overall mass of excitable tissue in the left atrium.
Owner:MEDTRONIC INC
Vagal nerve stimulation using vascular implanted devices for treatment of atrial fibrillation
An abnormally rapid ventricular cardiac rate that results from atrial fibrillation can be reduced by stimulating a vagal nerve of the heart. An apparatus for such stimulation includes a power transmitter that emits a radio frequency signal. A stimulator, implanted in a blood vessel adjacent the vagal nerve, has a pair of electrodes and an electrical circuit thereon. The electrical circuit receives the radio frequency signal and derives an electrical voltage from the energy of that signal. The electrical voltage is applied in the form of pulses to the pair of electrodes, thereby stimulating the vagal nerve. The pattern of that stimulating pulses can be varied in response to characteristics of the atrial fibrillation or the ventricular contractions.
Owner:KENERGY INC
Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
This invention is related to a tissue ablation system and method that treats atrial arrhythmia by ablating a circumferential region of tissue at a location where a pulmonary vein extends from an atrium. The system includes a circumferential ablation member with an ablation element and also includes a delivery assembly for delivering the ablation member to the location. The circumferential ablation member is generally adjustable between different configurations to allow both the delivery through a delivery sheath into the atrium and the ablative coupling between the ablation element and the circumferential region of tissue.
Owner:ATRIONIX
Tissue ablation device assembly and method of electrically isolating a pulmonary vein ostium from an atrial wall
This invention is related to a tissue ablation system and method that treats atrial arrhythmia by ablating a circumferential region of tissue at a location where a pulmonary vein extends from an atrium. The system includes a circumferential ablation member with an ablation element and also includes a delivery assembly for delivering the ablation member to the location. The circumferential ablation member is generally adjustable between different configurations to allow both the delivery through a delivery sheath into the atrium and the ablative coupling between the ablation element and the circumferential region of tissue.
Owner:ATRIONIX
Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
This invention is related to a tissue ablation system and method that treats atrial arrhythmia by ablating a circumferential region of tissue at a location where a pulmonary vein extends from an atrium. The system includes a circumferential ablation member with an ablation element and also includes a delivery assembly for delivering the ablation member to the location. The circumferential ablation member is generally adjustable between different configurations to allow both the delivery through a delivery sheath into the atrium and the ablative coupling between the ablation element and the circumferential region of tissue.
Owner:ATRIONIX
Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
This invention is related to a tissue ablation system and method that treats atrial arrhythmia by ablating a circumferential region of tissue at a location where a pulmonary vein extends from an atrium. The system includes a circumferential ablation member with an ablation element and also includes a delivery assembly for delivering the ablation member to the location. The circumferential ablation member is generally adjustable between different configurations to allow both the delivery through a delivery sheath into the atrium and the ablative coupling between the ablation element and the circumferential region of tissue.
Owner:ATRIONIX
Method and apparatus for percutaneous reduction of anterior-posterior diameter of mitral valve
A method and apparatus for treating mitral regurgitation by approximating the septal and lateral (clinically referred to as anterior and posterior) annulus of the mitral valve. The distal end of the device is inserted into the coronary sinus of the heart and the proximal end of the device rests within the right atrium along the tendon of Todaro and extends to at least the membranous septum of the tricuspid valve. Because the coronary sinus approximates the lateral (posterior) annulus of the mitral valve and the tendon of Todaro approximates the septal (anterior) annulus of the mitral valve, the device encircles approximately one half of the mitral valve annulus. The apparatus is then adapted to deform the underlying structures i.e. the septal annulus and lateral annulus of the mitral valve in order to move the posterior leaflet anteriorly and the anterior leaflet posteriorly and thereby improve leaflet coaptation and eliminate mitral regurgitation.
Owner:KARDIUM
Medical device for use in bodily lumens, for example an atrium
ActiveUS20090131930A1Improve abilitiesConvenient location informationDiagnostic recording/measuringSensorsAtrial cavityPermittivity
A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and / or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
Owner:KARDIUM
Method and system for treatment of atrial tachyarrhythmias
A method of and a system for treatment of atrial tachyarrhythmias. The system includes a set of hemostats having elongated opposing jaws carrying mechanisms for applying ablation energy along the jaws. The jaws having straight and curved configurations selected to allow arrangement of the jaws of along opposite sides of walls of a patient's atrium. Treatment is accomplished by applying of ablation energy to the walls of a patient's artria to create lines of lesion corresponding generally to incisions employed in a Maze type procedure.
Owner:MEDTRONIC INC
Pulmonary vein valve implant
InactiveUS20050273160A1Reduced likelihoodReduce severityStentsBronchiPulmonary vasculatureAtrial cavity
The present invention involves placing a valve between the left atrium and the lung to prevent regurgitant flow from increasing the pulmonary pressures, which may lead to pulmonary edema and congestion. Mitral stenosis or poor synchronization of the mitral valve may add additional pressures to the left atrium thus raising the pulmonary pressures and leading to congestion in the lung vasculature. By blocking the additional pressures from the mitral regurgitant flow from reaching the pulmonary circulation, the left atrium may act as a sealed vessel to allow additional aortic output. The valve placement can be intralumenal or attached to the ostium of the atrium. The device can be placed via the vascular conduits or through a surgical procedure into the pulmonary circulation. One or more devices may be placed in each of the four pulmonary veins. Additionally only one, two, three or all four veins may be implanted with the valve as desired by the physician.
Owner:DIRECT FLOW MEDICAL INC
Stent for arterialization of the coronary sinus and retrograde perfusion of the myocardium
The present invention concerns a novel stent and a method for communicating oxygenated blood directly from the left ventricle to the coronary sinus to provide retrograde perfusion to the myocardium. The stent is placed substantially within the coronary sinus with its trailing end protruding into the right atrium and the leading end protruding into the left ventricle. The stent has a smaller passageway at or near the trailing (right ventricular) end and at or near the leading (left ventricle) end, and has a covering at the trailing end. The smaller passageway and the cover at the trailing end to promote retrograde flow into the venous system of the hear and specifically the myocardium of the left ventricle and to reduce a significant left-to-right shunt.
Owner:MARTIN ERIC C
Devices and methods for coronary sinus pressure relief
A method and devices for relieving pressure in the left atrium of a patient's heart is disclosed. The method includes using an ablative catheter in a minimally invasive procedure to prepare an opening from the coronary sinus into a left atrium of the patient's heart. Once the opening is prepared, the opening may be enlarged by a technique such as expanding a balloon within the opening. A stent is then placed within the coronary sinus of the patient, with a transverse portion expanding within the opening, allowing blood to flow from the left atrium to the coronary sinus and then to the right atrium. Pressure within the left atrium is thus relieved.
Owner:DC DEVICES
Cardiac CT system and method for planning atrial fibrillation intervention
A method for planning atrial fibrillation (AF) intervention for a patient includes obtaining acquisition data from a medical imaging system, and generating a 3D model of the left atrium and pulmonary veins of the patient. One or more left atrial anatomical landmarks are identified on the 3D model, and saved views of the 3D model are registered on an interventional system. One or more of the registered saved views are visualized with the interventional system.
Owner:GE MEDICAL SYST GLOBAL TECH CO LLC +1
Cardiac CT system and method for planning left atrial appendage isolation
ActiveUS7747047B2Physical therapies and activitiesUltrasonic/sonic/infrasonic diagnosticsAnatomical landmarkAtrial cavity
A method for planning left atrial appendage (LAA) occlusion for a patient includes obtaining acquisition data from a medical imaging system, and generating a 3D model of the left atrium of the patient. One or more left atrial anatomical landmarks are identified on the 3D model, and saved views of the 3D model are registered on an interventional system. One or more of the registered saved views are visualized with the interventional system.
Owner:GE MEDICAL SYST GLOBAL TECH CO LLC +1
Methods and devices for occlusion of an atrial appendage
Some embodiments of the invention provide a system for occluding a left atrial appendage of a patient. Some embodiments of the system can include a ring occluder that can be positioned around the left atrial appendage and a ring applicator to position the ring occluder with respect to the left atrial appendage. One embodiment discloses a method of accessing endocardial surfaces of the heart through the atrial appendage. Additional embodiments of the invention provide a clip occluder that can be positioned around the left atrial appendage. A clip applicator can position the clip occluder with respect to the left atrial appendage.
Owner:MEDTRONIC INC
External atrial defibrillator and method for personal termination of atrial fibrillation
An atrial defibrillator includes a portable, non-implantable housing, a pair of defibrillator pads, a shock generator, and an analyzer. The pads are applied to the outside of a patient's body, and the shock generator delivers a shock to the patient via the pads. The analyzer receives a cardiac signal from the patient, determines from the signal whether the patient is experiencing atrial fibrillation, and enables the shock generator if the patient is experiencing atrial fibrillation. Unlike conventional external atrial defibrillators, such an atrial defibrillator can be used by a layperson in the comfort of a patient's own home. Furthermore, such a defibrillator does not cause the surgery-related problems associated with implantable atrial defibrillators. Moreover, because the patient can choose when to receive a shock, such a defibrillator is less likely to surprise and embarrass the patient than automatic implantable defibrillators are.
Owner:KONINKLIJKE PHILIPS ELECTRONICS NV
Treatment of atrial fibrillation using high-frequency pacing and ablation of renal nerves
ActiveUS20120143097A1Lower blood pressureReduce harmUltrasound therapyElectrotherapyAtrial cavityRenal nerve
A method for the treatment of a patient for the purpose of lowering blood pressure and / or treating cardiac arrhythmias, particularly atrial fibrillation includes the insertion of an ablation catheter into the lumen of a renal artery. The ablation catheter is equipped with an electrode that can stimulate the wall tissue in the renal artery to help identify the location of a renal nerve. High-frequency stimulation of the renal nerve causes a decrease in the blood pressure of the patient thereby indicating that a renal nerve is nearby. The ablation catheter is used to ablate the renal nerve using radiofrequency, ultrasound, microwave energy or cryogenic cooling. An irrigated ablation catheter may be used to decrease damage to cells in the wall of the lumen of the renal artery other than the renal nerve, such as the endothelial cells.
Owner:BIOSENSE WEBSTER (ISRAEL) LTD
Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
This invention is related to a tissue ablation system and method that treats atrial arrhythmia by ablating a circumferential region of tissue at a location where a pulmonary vein extends from an atrium. The system includes a circumferential ablation member with an ablation element and also includes a delivery assembly for delivering the ablation member to the location. The circumferential ablation member is generally adjustable between different configurations to allow both the delivery through a delivery sheath into the atrium and the ablative coupling between the ablation element and the circumferential region of tissue.
Owner:ATRIONIX
Stent for arterialization of the coronary sinus and retrograde perfusion of the myocardium
The present invention concerns a novel stent and a method for communicating oxygenated blood directly from the left ventricle to the coronary sinus to provide retrograde perfusion to the myocardium. The stent is placed substantially within the coronary sinus with its trailing end protruding into the right atrium and the leading end protruding into the left ventricle. The stent has a smaller passageway at the trailing (right ventricular) end and at the leading (left ventricle) end, and has a covering at the trailing end. The smaller passageway and the cover at the trailing end to promote retrograde flow into the venous system of the heart and specifically the myocardium of the left ventricle and to reduce a significant left-to-right shunt.
Owner:MARTIN ERIC C
Medical device for use in bodily lumens, for example an atrium
ActiveUS20110172658A1Increase capacityConvenient location informationSurgical instrument detailsDiagnostic recording/measuringAtrial cavityProximate
Owner:KARDIUM
Methods of cardiac ablation in the vicinity of the right inferior pulmonary vein
The present invention provides devices and methods for the treatment of atrial fibrillation. In one embodiment a method for ablating tissue about an ostium of a right inferior vein of a heart includes positioning a sheath catheter having a deflectable distal end segment with a bent tip element in the left atrium of a heart, causing the distal end segment to deflect in a compound curve as the catheter is advanced towards an ostium of a right inferior vein, orienting said sheath catheter such that an ablation instrument can be delivered through the sheath catheter to a position proximal to the right inferior vein, and activating the ablation instrument to form at least one lesion about the right inferior vein.
Owner:CARDIOFOCUS INC
Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing microporous balloon
InactiveUS7449018B2Inhibit and reduce rateMinimize and inhibit biochemical eventCatheterDiagnostic recording/measuringAtrial cavityWorking fluid
An enhanced method and device are provided to inhibit or reduce restenosis following angioplasty or stent placement. A porous balloon-tipped catheter is disposed in the area treated or opened through balloon angioplasty immediately following angioplasty. The balloon, which can have a dual balloon structure, may be delivered through a guiding catheter and over a guidewire already in place. A fluid such as a perfluorocarbon flows into the balloon to freeze the tissue adjacent the balloon, this cooling being associated with reduction of restenosis. A similar catheter may be used to reduce atrial fibrillation by inserting and inflating the porous balloon such that an exterior surface of the balloon, as well as a portion of the cold working fluid, from the microporosity contacts at least a partial circumference of the portion of the pulmonary vein adjacent the left atrium.
Owner:ZOLL CIRCULATION
Portable ECG monitor and method for atrial fibrillation detection
An apparatus and method for detecting an atrial fibrillation through monitoring the R—R intervals of a patient's QRS complexes. Ratios of the current R—R interval are made to previous R—R intervals. Multiple moving averages are taken of the ratio results. The ratios are compared to a validating threshold and if the particular ratio is within a selected range, a moving average is calculated with inclusion of the present R—R interval. If the ratio is outside the range, a moving average is calculated without inclusion of the current R—R interval. The moving averages are combined and this difference average is compared to a trigger threshold. If the difference average exceeds the threshold, an atrial fibrillation is determined to exist, a memory trigger is provided, and the QRS complex data within a selected period of time about the atrial fibrillation event are recorded and removed from overwrite status in the memory. A reset threshold, differing from the trigger threshold, is used and if the difference average falls below the reset threshold, the method and apparatus are re-enabled to record a new AFIB event.
Owner:LIFEWATCH SERVICES
Cardiac pacing using adjustable atrio-ventricular delays
A pacing system for providing optimal hemodynamic cardiac function for parameters such as contractility (peak left ventricle pressure change during systole or LV+dp / dt), or stroke volume (aortic pulse pressure) using system for calculating atrio-ventricular delays for optimal timing of a ventricular pacing pulse. The system providing an option for near optimal pacing of multiple hemodynamic parameters. The system deriving the proper timing using electrical or mechanical events having a predictable relationship with an optimal ventricular pacing timing signal.
Owner:CARDIAC PACEMAKERS INC
Cardiac devices and methods for minimally invasive repair of ischemic mitral regurgitation
ActiveUS8292884B2Eliminate bendingEffective closureIncision instrumentsDiagnosticsChordae tendineaeAtrial cavity
Novel apparatus and minimally invasive methods to treat atrioventricular valve regurgitation that is a result of tethering of chordae attaching atrioventricular valve leaflets to muscles of the heart, such as papillary muscles and muscles in the heart wall, thereby restricting the closure of the leaflets. Catheter embodiments for delivering and positioning chordal severing and elongating instruments are described.
Owner:THE GENERAL HOSPITAL CORP
Guided procedures for treating atrial fibrillation
Owner:BIOSENSE WEBSTER INC
Implantable cardiac stimulation device and method that discriminates between and treats atrial tachycardia and atrial fibrillation
An implantable cardiac stimulation device discriminates and treats accelerated atrial arrhythmias of a patient's heart. The device includes a sensing circuit that senses cardiac activity of one of the patient's atria to provide an atrial activity signal, a detector that detects an accelerated atrial arrhythmia of the patient's heart, and a classifying circuit that measures relative correspondence between successive P waves of the atrial activity signal to classify the detected accelerated atrial arrhythmia as either atrial tachycardia or atrial fibrillation. A therapy circuit provides anti-tachycardia pacing therapy responsive to a classified atrial tachycardia and defibrillation therapy responsive to a classified atrial fibrillation.
Owner:PACESETTER INC
Method for accessing the left atrial appendage with a balloon-tipped transeptal sheath
A method for accessing the left atrial appendage with a balloon-tipped transseptal sheath is disclosed. A transseptal sheath is delivered to the left atrium through the intraatrial septum from the right atrium. The balloon tip may be inflated to prevent the transseptal sheath from falling proximally into the right atrium. The inflated balloon tip permits safe probing and exploration of the left atrial appendage and facilitates safe maintenance of the position of the transseptal sheath within the left atrial appendage while delivering an implantable device to the left atrial appendage.
Owner:BOSTON SCI SCIMED INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com